Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...

Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...

The former 'Entertainment Tonight' co-host revealed in 2015 that he had been diagnosed with a rare form of prostate cancer ...

Patients in Leicestershire and Rutland now have access to a new state-of-the-art MRI scanner at the Leicester General Hospital.

Recognising these subtle body changes can lead to an earlier diagnosis, when treatment is more likely to be successful ...

I revved up my longevity protocols and sought out the latest predictive screenings. Was I seizing control of my health or ...

Sometimes waiting for symptoms to appear may be too late when it comes to detecting cancer. Dr Vass shares tests that can help with early detection.

The research lays a foundation for the possibility that aggressive prostate cancer can probably be detected through a few drops of semen or blood in the long term. Prostate cancer is the most common ...

Incidental detection has increased with ubiquitous CT/MRI, inflating early-stage ‘small renal mass’ diagnoses and complicating interpretation of a ~5% rise in <50-year incidence. Obesity, hypertension ...

DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to ca ...

The integration of genomic testing into cancer screening enables diagnostics to break away from conventional, one-size-fits-all protocols.